Short Interest in Croda International PLC Unsponsored ADR (OTCMKTS:COIHY) Drops By 89.5%

Croda International PLC Unsponsored ADR (OTCMKTS:COIHY) was the target of a significant decline in short interest during the month of May. As of May 15th, there was short interest totaling 1,749 shares, a decline of 89.5% from the April 30th total of 16,585 shares. Currently, 0.0% of the company’s shares are sold short. Based on an average daily trading volume, of 14,381 shares, the short-interest ratio is presently 0.1 days.

Wall Street Analysts Forecast Growth

COIHY has been the topic of a number of recent research reports. Zacks Research cut shares of Croda International from a “hold” rating to a “strong sell” rating in a research note on Tuesday, April 28th. Kepler Capital Markets upgraded shares of Croda International from a “reduce” rating to a “hold” rating in a research report on Tuesday, March 31st. One investment analyst has rated the stock with a Strong Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold”.

Croda International Price Performance

Croda International stock remained flat at $20.27 during midday trading on Thursday. 1,868 shares of the company traded hands, compared to its average volume of 5,961. The firm has a 50 day moving average price of $19.25 and a two-hundred day moving average price of $19.01. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.99 and a quick ratio of 1.18. Croda International has a twelve month low of $16.26 and a twelve month high of $22.29.

About Croda International

Croda International plc is a UK-based specialty chemicals company headquartered in East Yorkshire, England. Established in 1925, Croda has built a global reputation for developing and manufacturing high-performance ingredients derived primarily from natural oils and renewable resources. The company’s research-driven approach has enabled it to innovate across a wide range of sectors, delivering solutions that combine efficacy, sustainability and compliance with stringent regulatory standards.

Croda’s operations are organized around three core segments: Personal Care, Life Sciences and Performance Technologies.